Kimberly-Clark(US:KMB) ZACKS·2025-01-23 15:21Core Viewpoint - Kimberly-Clark (KMB) is expected to report quarterly earnings of $1.50 per share, a decline of 0.7% year-over-year, with revenues forecasted at $4.84 billion, down 2.6% from the previous year [1]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised downward by 0.3%, indicating a collective reassessment by analysts [2]. - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock [3]. Revenue Projections - Analysts project 'Net Sales- Personal Care' to reach $2.59 billion, reflecting a -0.7% change from the prior-year quarter [5]. - 'Net Sales- K-C Professional' is estimated at $738.73 million, indicating a -9.5% change year-over-year [5]. - 'Net Sales- Corporate & Other' is expected to be $11.67 million, down 2.8% from the previous year [5]. - 'Net Sales- Consumer Tissue' is projected at $1.52 billion, a -1.3% change year-over-year [6]. - 'Geographic Revenue- Outside North America' is forecasted at $2.19 billion, down 3.3% year-over-year [6]. - 'Geographic Revenue- North America' is expected to reach $2.71 billion, reflecting a -2.1% change from the year-ago quarter [6]. Profitability Metrics - 'Operating Profit- Personal Care' is expected to be $464.63 million, compared to $429 million in the same quarter last year [8]. - 'Operating Profit- K-C Professional' is projected at $150.32 million, slightly down from $151 million in the previous year [8]. - 'Operating Profit- Consumer Tissue' is estimated to reach $264.95 million, compared to $269 million in the same quarter last year [9]. Market Performance - Kimberly-Clark shares have decreased by 4.6% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.7% [9].